Compare AKAM & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKAM | HOLX |
|---|---|---|
| Founded | 1998 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.3B | 16.9B |
| IPO Year | 1999 | 1995 |
| Metric | AKAM | HOLX |
|---|---|---|
| Price | $155.60 | $76.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 13 |
| Target Price | ★ $107.87 | $77.89 |
| AVG Volume (30 Days) | 6.4M | ★ 95.4M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.71 | ★ 0.79 |
| Revenue | $2,502,996,000.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $8.53 | $4.74 |
| Revenue Next Year | $7.09 | $5.03 |
| P/E Ratio | $225.86 | ★ $96.23 |
| Revenue Growth | ★ 6.96 | 1.74 |
| 52 Week Low | $69.79 | $63.19 |
| 52 Week High | $165.45 | $76.07 |
| Indicator | AKAM | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.05 | 69.09 |
| Support Level | $87.55 | $75.10 |
| Resistance Level | $165.45 | N/A |
| Average True Range (ATR) | 6.27 | 0.19 |
| MACD | -0.20 | 0.03 |
| Stochastic Oscillator | 65.54 | 95.19 |
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.